1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea
2Medical Intensive Care Unit, Asan Medical Center, Seoul, Korea
3Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Copyright © 2021 The Korean Society of Critical Care Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICT OF INTEREST
No potential conflict of interest relevant to this article was reported.
AUTHOR CONTRIBUTIONS
Conceptualization: CML. Data curation: YC, KRK. Formal analysis: YC. Methodology: CML, YC. Project administration: CML, YC, KRK. Visualization: CML, YC. Writing–original draft: CML, YC. Writing–review & editing: YC, CML, YK, JWH, SBH.
Characteristics | All patients (n=210) | Non-beneficial admission (n=22) | Beneficial admission (n=166) | Indeterminate state (n=22) | P-value |
---|---|---|---|---|---|
Age (yr) | 64±14 | 63±14 | 64±14 | 68±15 | 0.474 |
Male | 139 (66) | 15 (68) | 112 (68) | 12 (55) | 0.474 |
Underlying disease | |||||
DM | 66 (31) | 8 (36) | 50 (30) | 8 (36) | 0.730 |
Hypertension | 91 (43) | 7 (32) | 72 (43) | 12 (55) | 0.314 |
Hepatitis | 20 (10) | 0 | 16 (11) | 1 (5) | 0.201 |
Pulmonary tuberculosis | 32 (15) | 3 (14) | 24 (15) | 5 (23) | 0.570 |
Malignancy | 71 (34) | 11 (50) | 54 (33) | 6 (27) | 0.210 |
Hematologic | 24 (11) | 4 (18) | 19 (11) | 1 (5) | 0.350 |
Solid tumor | 47 (22) | 7 (32) | 35 (21) | 5 (23) | 0.457 |
Liver cirrhosis | 17 (8) | 3 (14) | 12 (7) | 2 (9) | 0.526 |
COPD | 14 (7) | 0 | 13 (8) | 1 (5) | 0.602 |
ESRD | 9 (4) | 1 (5) | 6 (4) | 2 (9) | 0.285 |
Others | 2 (1) | 0 | 1 (1) | 1 (5) | 0.376 |
Reason for ICU admission | |||||
Acute respiratory failure | 109 (52) | 10 (46) | 83 (50) | 16 (73) | 0.109 |
Sepsis/septic shock | 38 (18) | 4 (18) | 32 (20) | 2 (9) | 0.615 |
Postoperative care | 16 (8) | 0 | 16 (10) | 0 | 0.119 |
Acute liver failure | 13 (6) | 1 (5) | 10 (6) | 2 (9) | 0.866 |
Hemorrhagic shock | 11 (5) | 2 (9) | 9 (5) | 0 | 0.448 |
Heart failure/ACS | 5 (2) | 0 | 4 (2) | 1 (5) | 0.695 |
Acute renal failure | 5 (2) | 0 | 4 (2) | 1 (5) | 0.695 |
CPCR survivor | 5 (2) | 4 (18) | 1 (1) | 0 | 0.001 |
For procedure | 4 (2) | 0 | 4 (2) | 0 | 1.000 |
Acute cerebral hemorrhage/stroke | 2 (1) | 1 (5) | 1 (1) | 0 | 0.376 |
For surgery | 1 (1) | 0 | 1 (1) | 0 | 0.119 |
Others | 1 (1) | 0 | 1 (1) | 0 | 1.000 |
APACHE II score at ICU admission | 25±9 | 30±8 | 26±9 | 29±7 | <0.001a |
Route of ICU admission | |||||
General ward | 122 (58) | 12 (55) | 97 (58) | 13 (59) | 0.968 |
Emergency room | 79 (38) | 10 (25) | 62 (37) | 7 (32) | 0.639 |
Transfer from other hospital | 9 (4) | 0 | 7 (4) | 2 (9) | 0.437 |
DNR status | |||||
Before ICU admission | 2 (1) | 0 | 1 (1) | 1 (1) | 0.179 |
During ICU stay | 61 (29) | 12 (55) | 35 (21) | 14 (64) | <0.001 |
During the entire hospitalization | 74 (35) | 12 (55) | 47 (28) | 15 (68) | <0.001 |
Values are presented as mean±standard deviation or number (%).
DM: diabetes mellitus; COPD: chronic obstructive pulmonary disease; ESRD: end-stage renal disease; ICU: intensive care unit; ACS: acute coronary syndrome; CPCR: cardiopulmonary cerebral resuscitation; APACHE: Acute Physiology and Chronic Health Evaluation; DNR: do-not-resuscitate.
a Non-beneficial admission group versus beneficial admission group, P=0.001; beneficial admission group versus indeterminate state group, P=0.011; non-beneficial admission group versus indeterminate state group, P=0.534.
Characteristics | Day 1 | Day 3 |
---|---|---|
Perception of the intensivists | (n=210) | (n=202a) |
Non-beneficial admission | 22 (10) | 22 (11) |
Beneficial admission | 166 (79) | 159 (79) |
Indeterminate state | 22 (10) | 21 (10) |
Reason for perception as non-beneficial admission | (n=22) | (n=22) |
Serious underlying disease and irreversibility | 18 (82) | 19 (86) |
Serious neurologic condition | 2 (9) | 3 (14) |
Imminent death within 7 days | 2 (9) | 0 |
Variable for quality of life | ICU admission (n=91) | 6 Months after ICU discharge (n=87)a | Interval improvementa |
---|---|---|---|
Sensory/cognitive ability | 37 (43) | ||
No ability | 3 (3) | 0 | |
Severely limited | 24 (26) | 5 (6) | |
Mildly limited | 22 (24) | 9 (10) | |
No limitation | 42 (46) | 73 (84) | |
Physical activity | 75 (86) | ||
Bedridden | 53 (58) | 4 (4) | |
Able to sit up | 34 (37) | 22 (24) | |
Able to occasionally ambulate | 2 (2) | 23 (25) | |
Able to often ambulate | 2 (2) | 38 (42) | |
Degree of mobility | 61 (70) | ||
No mobility | 10 (11) | 2 (2) | |
Severely limited | 47 (52) | 12 (13) | |
Mildly limited | 27 (30) | 30 (33) | |
No limitation | 7 (8) | 43 (47) |
Values are presented as mean±standard deviation or number (%).
ICU: intensive care unit; DM: diabetes mellitus; COPD: chronic obstructive pulmonary disease; ESRD: end-stage renal disease; ACS: acute coronary syndrome; CPCR: cardiopulmonary cerebral resuscitation; CVA: cerebrovascular accident (hemorrhage or stroke); APACHE II: Acute Physiology and Chronic Health Evaluation II; GW: general ward; ER: emergency room.
Characteristics | All patients (n=210) | Non-beneficial admission (n=22) | Beneficial admission (n=166) | Indeterminate state (n=22) | P-value |
---|---|---|---|---|---|
Age (yr) | 64±14 | 63±14 | 64±14 | 68±15 | 0.474 |
Male | 139 (66) | 15 (68) | 112 (68) | 12 (55) | 0.474 |
Underlying disease | |||||
DM | 66 (31) | 8 (36) | 50 (30) | 8 (36) | 0.730 |
Hypertension | 91 (43) | 7 (32) | 72 (43) | 12 (55) | 0.314 |
Hepatitis | 20 (10) | 0 | 16 (11) | 1 (5) | 0.201 |
Pulmonary tuberculosis | 32 (15) | 3 (14) | 24 (15) | 5 (23) | 0.570 |
Malignancy | 71 (34) | 11 (50) | 54 (33) | 6 (27) | 0.210 |
Hematologic | 24 (11) | 4 (18) | 19 (11) | 1 (5) | 0.350 |
Solid tumor | 47 (22) | 7 (32) | 35 (21) | 5 (23) | 0.457 |
Liver cirrhosis | 17 (8) | 3 (14) | 12 (7) | 2 (9) | 0.526 |
COPD | 14 (7) | 0 | 13 (8) | 1 (5) | 0.602 |
ESRD | 9 (4) | 1 (5) | 6 (4) | 2 (9) | 0.285 |
Others | 2 (1) | 0 | 1 (1) | 1 (5) | 0.376 |
Reason for ICU admission | |||||
Acute respiratory failure | 109 (52) | 10 (46) | 83 (50) | 16 (73) | 0.109 |
Sepsis/septic shock | 38 (18) | 4 (18) | 32 (20) | 2 (9) | 0.615 |
Postoperative care | 16 (8) | 0 | 16 (10) | 0 | 0.119 |
Acute liver failure | 13 (6) | 1 (5) | 10 (6) | 2 (9) | 0.866 |
Hemorrhagic shock | 11 (5) | 2 (9) | 9 (5) | 0 | 0.448 |
Heart failure/ACS | 5 (2) | 0 | 4 (2) | 1 (5) | 0.695 |
Acute renal failure | 5 (2) | 0 | 4 (2) | 1 (5) | 0.695 |
CPCR survivor | 5 (2) | 4 (18) | 1 (1) | 0 | 0.001 |
For procedure | 4 (2) | 0 | 4 (2) | 0 | 1.000 |
Acute cerebral hemorrhage/stroke | 2 (1) | 1 (5) | 1 (1) | 0 | 0.376 |
For surgery | 1 (1) | 0 | 1 (1) | 0 | 0.119 |
Others | 1 (1) | 0 | 1 (1) | 0 | 1.000 |
APACHE II score at ICU admission | 25±9 | 30±8 | 26±9 | 29±7 | <0.001 |
Route of ICU admission | |||||
General ward | 122 (58) | 12 (55) | 97 (58) | 13 (59) | 0.968 |
Emergency room | 79 (38) | 10 (25) | 62 (37) | 7 (32) | 0.639 |
Transfer from other hospital | 9 (4) | 0 | 7 (4) | 2 (9) | 0.437 |
DNR status | |||||
Before ICU admission | 2 (1) | 0 | 1 (1) | 1 (1) | 0.179 |
During ICU stay | 61 (29) | 12 (55) | 35 (21) | 14 (64) | <0.001 |
During the entire hospitalization | 74 (35) | 12 (55) | 47 (28) | 15 (68) | <0.001 |
Characteristics | Day 1 | Day 3 |
---|---|---|
Perception of the intensivists | (n=210) | (n=202 |
Non-beneficial admission | 22 (10) | 22 (11) |
Beneficial admission | 166 (79) | 159 (79) |
Indeterminate state | 22 (10) | 21 (10) |
Reason for perception as non-beneficial admission | (n=22) | (n=22) |
Serious underlying disease and irreversibility | 18 (82) | 19 (86) |
Serious neurologic condition | 2 (9) | 3 (14) |
Imminent death within 7 days | 2 (9) | 0 |
Variable for quality of life | ICU admission (n=91) | 6 Months after ICU discharge (n=87) |
Interval improvement |
---|---|---|---|
Sensory/cognitive ability | 37 (43) | ||
No ability | 3 (3) | 0 | |
Severely limited | 24 (26) | 5 (6) | |
Mildly limited | 22 (24) | 9 (10) | |
No limitation | 42 (46) | 73 (84) | |
Physical activity | 75 (86) | ||
Bedridden | 53 (58) | 4 (4) | |
Able to sit up | 34 (37) | 22 (24) | |
Able to occasionally ambulate | 2 (2) | 23 (25) | |
Able to often ambulate | 2 (2) | 38 (42) | |
Degree of mobility | 61 (70) | ||
No mobility | 10 (11) | 2 (2) | |
Severely limited | 47 (52) | 12 (13) | |
Mildly limited | 27 (30) | 30 (33) | |
No limitation | 7 (8) | 43 (47) |
Characteristics | ICU outcome |
P-value | 6-month outcome |
P-value | |||
---|---|---|---|---|---|---|---|
All patients (n=210) | Survivor (n=146) | Non-survivor (n=64) | Survivor (n=91) | Non-survivor (n=119) | |||
Age (yr) | 64±14 | 64±15 | 66±13 | 0.310 | 64±16 | 65±13 | 0.809 |
Male | 139 (66) | 96 (66) | 43 (67) | 0.84 | 52 (57) | 87 (73) | 0.015 |
Underlying disease | |||||||
DM | 66 (31) | 45 (31) | 21 (33) | 0.775 | 31 (34) | 35 (29) | 0.155 |
Hypertension | 91 (43) | 66 (45) | 25 (39) | 0.408 | 41 (45) | 50 (42) | 0.660 |
Hepatitis | 20 (10) | 11 (8) | 9 (14) | 0.138 | 7 (8) | 13 (11) | 0.429 |
Pulmonary tuberculosis | 32 (15) | 19 (13) | 13 (20) | 0.176 | 10 (11) | 22 (19) | 0.134 |
Malignancy | 71 (34) | 49 (34) | 22 (34) | 0.909 | 18 (20) | 53 (45) | <0.001 |
Hematologic | 24 (11) | 15 (10) | 9 (14) | 0.427 | 7 (8) | 17 (14) | 0.137 |
Solid tumor | 47 (22) | 34 (23) | 13 (20) | 0.634 | 11 (12) | 36 (30) | 0.002 |
Liver cirrhosis | 17 (8) | 10 (7) | 7 (11) | 0.317 | 3 (3) | 14 (12) | 0.026 |
COPD | 14 (7) | 12 (8) | 2 (3) | 0.236 | 9 (10) | 5 (4) | 0.102 |
ESRD | 9 (4) | 7 (5) | 2 (3) | 0.725 | 7 (8) | 2 (2) | 0.042 |
Others | 2 (1) | 1 (1) | 1 (2) | 0.518 | 0 | 2 (2) | 0.507 |
Reason for ICU admission | |||||||
Acute respiratory failure | 109 (52) | 75 (51) | 34 (53) | 0.815 | 50 (55) | 59 (50) | 0.441 |
Sepsis/septic shock | 38 (18) | 29 (20) | 9 (14) | 0.315 | 16 (18) | 22 (19) | 0.866 |
Postoperative care | 16 (8) | 16 (11) | 0 | 0.003 | 10 (11) | 6 (5) | 0.107 |
Acute liver failure | 13 (6) | 8 (6) | 5 (8) | 0.541 | 5 (6) | 8 (7) | 0.714 |
Hemorrhagic shock | 11 (5) | 7 (5) | 4 (6) | 0.739 | 4 (4) | 7 (6) | 0.760 |
Heart failure/ACS | 5 (2) | 1 (1) | 4 (6) | 0.031 | 0 | 5 (4) | 0.071 |
Acute renal failure | 5 (2) | 3 (2) | 2 (3) | 0.642 | 3 (3) | 2 (2) | 0.654 |
CPCR survivor | 5 (2) | 1 (1) | 4 (6) | 0.031 | 0 (0) | 5 (4) | 0.071 |
For procedure | 5 (2) | 4 (3) | 1 (2) | 1.000 | 2 (2) | 3 (3) | 1.000 |
Acute CVA | 2 (1) | 1 (1) | 1 (2) | 0.518 | 0 | 2 (2) | 0.507 |
For surgery | 16 (8) | 16 (11) | 0 | 0.003 | 10 (11) | 6 (5) | 0.290 |
Others | 1 (1) | 1 (1) | 0 | 1.000 | 1 (1) | 0 | 0.433 |
APACHE II score at ICU admission* | 25±9 | 23±8 | 29±9 | <0.001 | 23±9 | 26±9 | 0.027 |
Route of ICU admission | |||||||
GW | 122 (58) | 83 (57) | 39 (61) | 0.58 | 47 (52) | 75 (63) | 0.098 |
ER | 79 (38) | 55 (38) | 24 (38) | 0.981 | 40 (44) | 39 (33) | 0.097 |
Transfer from other hospital | 9 (4) | 8 (6) | 1 (2) | 0.282 | 4 (4) | 5 (4) | 1.000 |
Day 1 perception of the intensivists | |||||||
Non-beneficial admission or indeterminate state | 44 (21) | 18 (12) | 26 (41) | <0.001 | 4 (4) | 40 (34) | <0.001 |
Day 3 perception of the intensivists | |||||||
Non-beneficial admission or indeterminate state | 43 (20) | 17 (12) | 26 (41) | <0.001 | 4 (4) | 39 (33) | <0.001 |
Variable | ICU mortality |
6-Month mortality |
||||||
---|---|---|---|---|---|---|---|---|
Univariate analysis |
Multivariate analysis |
Univariate analysis |
Multivariate analysis |
|||||
OR (95% CI) | P-value | OR (95% CI) | P-value | OR (95% CI) | P-value | OR (95% CI) | P-value | |
Male | 2.309 (1.141–3.642) | 0.016 | 2.616 (1.289–5.311) | 0.008 | ||||
Underlying disease | ||||||||
Malignant solid tumor | 3.154 (1.502–6.623) | 0.002 | 3.411 (1.480–7.861) | 0.004 | ||||
Liver cirrhosis | 3.911 (1.089–14.049) | 0.037 | 3.855 (0.976–15.226) | 0.054 | ||||
Reason for ICU admission | ||||||||
Heart failure/ACS | 9.667 (1.058–88.283) | 0.044 | 8.597 (0.818–90.333) | 0.073 | ||||
CPCR survivor | 9.667 (1.058–88.283) | 0.044 | ||||||
APACHE II score at ICU admission | 1.094 (1.052–1.137) | <0.001 | 1.074 (1.031–1.118) | <0.001 | 1.037 (1.004–1.071) | 0.029 | ||
Day 1 perception of the intensivists | ||||||||
Non-beneficial admission or indeterminate state | 4.865 (2.412–9.814) | <0.001 | 11.013 (3.77–32.17) | <0.001 | 4.983 (1.260–19.703) | 0.022 | ||
Day 3 perception of the intensivists | ||||||||
Non-beneficial admission or indeterminate state | 5.418 (2.645–11.101) | <0.001 | 4.049 (1.892–8.664) | <0.001 | 11.486 (3.919–33.663) | <0.001 | 4.459 (1.162–17.121) | 0.029 |
Values are presented as mean±standard deviation or number (%). DM: diabetes mellitus; COPD: chronic obstructive pulmonary disease; ESRD: end-stage renal disease; ICU: intensive care unit; ACS: acute coronary syndrome; CPCR: cardiopulmonary cerebral resuscitation; APACHE: Acute Physiology and Chronic Health Evaluation; DNR: do-not-resuscitate. Non-beneficial admission group versus beneficial admission group, P=0.001; beneficial admission group versus indeterminate state group, P=0.011; non-beneficial admission group versus indeterminate state group, P=0.534.
Values are presented as number (%). ICU: intensive care unit. On day 3, 202 of the 210 patients remained in the ICU.
Values are presented as number (%). ICU: intensive care unit. Four patients missing.
Values are presented as mean±standard deviation or number (%). ICU: intensive care unit; DM: diabetes mellitus; COPD: chronic obstructive pulmonary disease; ESRD: end-stage renal disease; ACS: acute coronary syndrome; CPCR: cardiopulmonary cerebral resuscitation; CVA: cerebrovascular accident (hemorrhage or stroke); APACHE II: Acute Physiology and Chronic Health Evaluation II; GW: general ward; ER: emergency room.
All patients: n=210. ICU: intensive care unit; OR: odds ratio; CI: confidence interval; ACS: acute coronary syndrome; CPCR: cardiopulmonary cerebral resuscitation; APACHE: Acute Physiology and Chronic Health Evaluation.